Impact of a Computerized Guidelines on the Management of Hypertension and Diabetes (ASTI)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00398944|
Recruitment Status : Completed
First Posted : November 14, 2006
Last Update Posted : July 27, 2010
|Condition or disease||Intervention/treatment||Phase|
|Diabetes Mellitus Hypertension||Device: Evaluation of the impact of a guideline based computerized decision support system.||Not Applicable|
Existing computer-based ordering systems for physicians provide drug-centred checks but offer little assistance for optimizing the overall patient-centred treatment strategy.
The ASTI project aims :
to design a guideline-based decision support system for diabetic and/or hypertensive patients, to help general practitioners :
- to carry out procedures (clinical and biological tests) according to guidelines (the recommended procedure at the recommended moment), and to get a synthetic view of all the elements they need to follow-up the patient
- to avoid prescription errors and to improve compliance with therapeutic guidelines. The " critic mode " operates as a background process and corrects the physician's prescription on the basis of automatically triggered elementary rules that account for isolated guideline recommendations. The " guided mode " directs the physician to the best treatment by browsing a comprehensive guideline knowledge base represented as a decision tree.
- To measure the impact of ASTI when it is implemented with an electronic medical record system. We adopt a randomized design, with the practice as the unit of randomization.
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||2715 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||Impact of a Computerized Decision Support System, Based on EBM French Guidelines, on the Management of Hypertension and Diabetes: a Randomised Controlled Trial in Primary Care|
|Study Start Date :||November 2006|
|Actual Primary Completion Date :||January 2008|
|Actual Study Completion Date :||May 2008|
- Patients who underwent the recommended procedures during the last 12 months [ Time Frame: 16 months ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00398944
|Paris, France, 75013|
|Principal Investigator:||Hector FALCOFF||Société de Formation Thérapeutique du Généraliste|